Gilbert G G Donders
Prof Gilbert G G Donders, MD, PhD is an expert in Gynecology at Antwerp University Hospital (Belgium). As of November 2026, ScienceLeadR ranks Gilbert G G Donders in the top 1% of experts worldwide for Vaginal Diseases and Vaginitis, and in the top 1% of experts in Belgium for Vulvar Diseases. Gilbert G G Donders has authored 252 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 842 (community average: 125). How the SLR is computed.
LeadR Profile
Gynecology
Subspecialties: Public Health - Oncology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1989 - 2026Antwerp University Hospital - Gynecologist
2012 - 2026
University of Antwerp - Professor
2013 - 2026
Number : 252
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| DeVEnIR Defining Vulvovaginal Candidiasis Elements of Infection and Remedy NCT06397248 — mycology, candidiasis, immunity, candidiasis, vulvovaginal, research, therapeutics, immunity, innate, communicable diseases, infections, women | N/A | Active not recruiting | 2024 |
| Assessing the Safety Immune Response and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis A Randomized Controlled Study NCT06190509 — candidiasis, safety, vaccines, immunity, candidiasis, vulvovaginal, candida, women | Phase 1/Phase 2 | Active not recruiting | 2023 |
| A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti cancer Therapy in Women With or at High Risk for Developing Hormone receptor Positive Breast Cancer NCT05587296 — cells, quality of life, estrogens, safety, breast neoplasms, uterus, neoplasms, hormones, signs and symptoms, drug-related side effects and adverse reactions, hot flashes, breast, records, therapeutics, progesterone, women | Phase 3 | Active not recruiting | 2022 |
LeadR Networks
Main global connection map